A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
All edits
Edits on 15 Mar, 2024
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Participating Facility
Health Conditions in Trial
Interventional Trial Phase
Phase 30
Intervention Treatment
Sepiapterin0
Intervention Type
Drug0
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+206 characters)
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
Article
Study summary
The main purpose of this trial is to evaluate the long-term efficacy of sepiapterin on preserving neurocognitive functioning in children with PKU when treatment is initiated in early childhood.
Infobox
Is a
NCT Number
Trial Recruitment Size
560
Trial Sponsor
Clinical Trial Start Date
February 29, 2024
0Primary Completion Date
February 28, 2031
0Study Completion Date
February 28, 2031
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Official Website
Official Name
A Phase 3b Open-Label Study of Long-Term Neurocognitive Outcomes in Children With Phenylketonuria Treated With Sepiapterin0
Last Updated
March 8, 2024
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Find more entities like A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.